Your browser doesn't support javascript.
loading
Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS).
Vecchierini, M F; Kilic-Huck, U; Quera-Salva, M A.
Affiliation
  • Vecchierini MF; Sleep Center, Hôtel-Dieu, Paris-Descartes University, 1, place du parvis Jean-Paul II, 75004 Paris, France. Electronic address: mfv.hotel.dieu@gmail.com.
  • Kilic-Huck U; Sleep Disorders Center Hôpitaux Universitaires de Strasbourg: Institut des neurosciences cellulaires et intégratives, CNRS-UPR 3212, 5, rue Blaise-Pascal, 67000 Strasbourg, France.
  • Quera-Salva MA; Sleep disorders Unit, Departement of Physiology, Hôpital Raymond-Poincaré, université de Saclay, EA 4047 AP-HP Saclay University, 92380 Garches, France.
Rev Neurol (Paris) ; 177(3): 245-259, 2021 Mar.
Article in En | MEDLINE | ID: mdl-32921425
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sleep Initiation and Maintenance Disorders / Melatonin Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Rev Neurol (Paris) Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sleep Initiation and Maintenance Disorders / Melatonin Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Rev Neurol (Paris) Year: 2021 Document type: Article